• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Sunday, August 5, 2018

    Offline Date

    Tuesday, March 5, 2019

    ACPE Expiration Date

    Sunday, June 13, 2021

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $0.00

    • Overview

      No bones about it – The National Osteoporosis Foundation (NOF) has estimated that eight million women already have osteoporosis, and another approximately 44 million may have low bone mass placing them at increased risk for osteoporosis.  Moreover, an estimated two million osteoporotic fractures occur every year in the United States; by 2025 that number may reach three million.  Osteoporosis sneaks up on most people. Often referred to as a “silent” disease, many patients never learn they have osteoporosis until they suffer a fracture.  This knowledge-based activity will educate pharmacists on the diagnosis and treatment of osteoporosis, as well as the importance of counseling patients to adhere to lifestyle modifications and treatment.

      Handouts

      • Slide Document :   18078H01_4pp.pdf
      • Slide Document :   18078H01_2pp.pdf

      Financial Support By

      Radius Health, Inc
    • Pharmacist

      Outline the incidence, prevalence and burden of osteoporosis
      Review the pharmacist's role in treating osteoporosis patients to include non-pharmacological therapy, patient and care giver educations and improving patient adherence to treatment
      Describe the risk factors, screening methods, and current treatment options for patients with osteoporosis to include those at high risk for fracture

      Pharmacy Technician

      List the treatment options for patients with osteoporosis, including those at high risk of fracture
      Identify the risk factors for osteoporosis
      Identify opportunities to refer patients to the pharmacist when patient education is needed including non-pharmacological therapy and medication adherence

      Nurse

      Outline the incidence, prevalence and burden of osteoporosis
      Review the pharmacist's role in treating osteoporosis patients to include non-pharmacological therapy, patient and care giver educations and improving patient adherence to treatment
      Describe the risk factors, screening methods, and current treatment options for patients with osteoporosis to include those at high risk for fracture
    • Activity Type

      Knowledge

      CE Broker

      20-628673

      Universal Activity Number

      Pharmacist 0798-0000-18-078-H01-P
      Pharmacy Technician 0798-0000-18-078-H01-T
      Nurse 0798-0000-18-078-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Brooke  Fidler, PharmD
      Associate Professor, LIU Pharmacy, Arnold & Marie Schwartz College of Pharmacy and Health Sciences

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).